Literature DB >> 19035995

Re: Using telemedicine for termination of pregnancy with mifepristone and misoprostol in settings where there is no access to safe services.

R Gomperts, G Kleiverda, K Gemzell, S Davies, K Jelinska.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19035995     DOI： 10.1111/j.1471-0528.2008.01923.x

Source DB:  PubMed          Journal:  BJOG        ISSN： 1470-0328            Impact factor:   6.531


× No keyword cloud information.
  3 in total

1.  Policy surveillance for a global analysis of national abortion laws.

Authors:  Patty Skuster; Jamie Menzel; Adrienne R Ghorashi; Megan Perkins
Journal:  Sex Reprod Health Matters       Date:  2022-12

2.  Medical abortion with mifepristone and home administration of misoprostol up to 63 days' gestation.

Authors:  Mette Løkeland; Ole Erik Iversen; Anders Engeland; Ingrid Økland; Line Bjørge
Journal:  Acta Obstet Gynecol Scand       Date:  2014-05-23       Impact factor: 3.636

3.  Self-managed medication abortion outcomes: results from a prospective pilot study.

Authors:  Heidi Moseson; Ruvani Jayaweera; Sarah Raifman; Brianna Keefe-Oates; Sofia Filippa; Relebohile Motana; Ijeoma Egwuatu; Belen Grosso; Ika Kristianingrum; Sybil Nmezi; Ruth Zurbriggen; Caitlin Gerdts
Journal:  Reprod Health       Date:  2020-10-27       Impact factor: 3.223
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.